Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Solta Medical Inc    SLTM   US83438K1034

SOLTA MEDICAL INC

 (SLTM)

1
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 

Solta Medical Inc. : Solta Medical to Present at the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorder Medical Device Conference

11/30/2011| 04:10pm US/Eastern
Recommend:
0

HAYWARD, Calif., Nov. 30, 2011 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today announced that it will present at the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorder Medical Device Conference at the St. Regis Hotel in San Francisco on Tuesday, December 6, 2011 at 9:40 am Pacific Time. Stephen J. Fanning, Chairman, President and Chief Executive Officer, will review the company's business strategy and recent corporate events.

Attendance at this conference is by invitation only. Solta will offer a live audio webcast of its presentation which may be accessed at the Investor Relations section of the Company's website at www.solta.com. An archived replay of the presentation will be available for 15 days, also at www.solta.com.

About Solta Medical, Inc.

Solta Medical, Inc. is a global leader in the medical aesthetics market providing innovative, safe, and effective solutions for patients that enhance and expand the practice of medical aesthetics for physicians. The company offers products to address a range of skin issues under the industry´s six premier brands: Thermage®, Fraxel®, liposonix®, Isolaz®, CLARO® and Clear + Brilliant®. Thermage is an innovative, non-invasive radiofrequency procedure for tightening and contouring skin. As the leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin. The liposonix system uses advanced high-intensity focused ultrasound (HIFU) technology to permanently destroy targeted fat just beneath the skin in the treatment areas of the abdomen and flanks as a noninvasive, nonsurgical approach to aesthetic waist circumference reduction. Isolaz was the first laser or light based system indicated for the treatment of inflammatory acne, comedonal acne, pustular acne, and mild-to-moderate inflammatory acne. CLARO is a personal care acne system that is the first FDA cleared over-the-counter IPL device that uses a powerful combination of both heat and light to clear skin quickly and naturally. Clear + Brilliant is a unique, cost-effective treatment that utilizes safe, fractional laser technology to correct and prevent early signs of aging and is FDA cleared and CE marked. Since 2002, over one million Thermage, Fraxel and Isolaz procedures have been performed in over 100 countries. For more information about Solta Medical, call 1-877-782-2286 or log on to www.Solta.com.

SOURCE Solta Medical, Inc.

Recommend :
0
Partner Area
React to this article
 
Latest news on SOLTA MEDICAL INC
05/06 SOLTA MEDICAL INC: Solta Medical Announces The Thermage® Total Tip
05/01 SOLTA MEDICAL INC: Solta Medical Reports First Quarter 2013 Results
04/17 SOLTA MEDICAL INC: Solta Medical to Report First Quarter 2013 Results and Host ..
04/15 SOLTA MEDICAL INC: Solta Medical Launches Clear + Brilliant® Simply Smart(TM) R..
03/12 SOLTA MEDICAL INC: Solta Medical to Present at the 25th Annual ROTH Growth Stoc..
02/26 SOLTA MEDICAL INC: Solta Medical Completes Acquisition Of Sound Surgical Techno..
02/19 SOLTA MEDICAL INC: Solta Medical Reports Fourth Quarter and Full Year 2012 Resu..
02/05 SOLTA MEDICAL INC: Solta Medical to Report Fourth Quarter 2012 Results Release ..
02/04 SOLTA MEDICAL INC: Solta Medical to Present at the Leerink Swann Global Healthc..
01/29 SOLTA MEDICAL INC: Solta Medical to Acquire Sound Surgical Technologies
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.